Curve Therapeutics
3 known investors
Curve Therapeutics uses its mammalian cell-based Microcycle discovery platform to develop cyclic peptide and small molecule drugs against intracellular targets. Its pipeline focuses on cancer, immunology, and inflammation.
Investors · 3
Competitors · 2
by search overlapVerve Therapeutics3 shared keywordsCambridge, MA biotech developing single-course in vivo base editing medicines to permanently lower cardiovascular disease risk.
Curvebio3 shared keywordsCurve Bio builds Whole-Body Intelligence models from its Whole-Body Atlas, a molecular map of the body, to power blood tests that monitor organ health in chronic disease patients. The company works in molecular diagnostics and biotechnology, focused on more accurate patient monitoring.
Companies competing with Curve Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Curve Therapeutics do?
- Curve Therapeutics uses its mammalian cell-based Microcycle discovery platform to develop cyclic peptide and small molecule drugs against intracellular targets. Its pipeline focuses on cancer, immunology, and inflammation.
- Who are Curve Therapeutics's investors?
- Curve Therapeutics's investors include Epidarex Capital, Pfizer Venture Investments, Columbus Venture Partners.